Lena Biosciences
Atlanta-based Lena Biosciences offers advanced biotech solutions for precision therapy testing.
Founded
2008Atlanta-based Lena Biosciences offers advanced biotech solutions for precision therapy testing.
Lena Biosciences, founded in Atlanta, is a biotechnology company dedicated to advancing precision therapy testing through innovative organ-on-a-chip and 3D cell culture products. Their core mission is to enhance the accuracy and efficacy of therapeutic testing, ultimately improving patient outcomes. Lena Biosciences offers a range of advanced biotech solutions, including tools and services for 3D cell culture, aimed at researchers and pharmaceutical companies focused on developing and testing new treatments.
The company has established partnerships with leading research institutions and biotech firms, contributing to significant advancements in the field of precision medicine. Notable investors and affiliated experts in biotechnology support Lena Biosciences, underscoring its credibility and potential for impact. Key achievements include the development of cutting-edge 3D cell culture tools that have been adopted by top-tier research labs. Lena Biosciences continues to influence the biotech industry by providing essential tools that facilitate more accurate and efficient drug development processes.
Companies similar to Lena Biosciences include 3D Biotek, Nano3D Biosciences, Viscient Bio and Aurita.
Lena Biosciences was founded in 2008.
Lena Biosciences' headquarters is located in Atlanta, GA, US.
Lena Biosciences' most recent funding round was for $252.1k (USD) in August 2020.
As of Aug 1, 2020, Lena Biosciences has disclosed funding of $2.6M (USD). Undisclosed round amounts are excluded.
Lena Biosciences has 5 employees as of Feb 4, 2024.
Aurita
auritabio.com
